The tender offer expired at the end of September 4, 2009. At that time, the depositary for the offer advised Covidien that 15.21 million shares of Power Medical Interventions (PMI) had been validly tendered and not withdrawn, representing approximately 87% of the outstanding PMI common shares.
All shares that were validly tendered and not withdrawn were accepted for purchase and paid for in accordance with the tender offer. An additional 247,765 shares, or approximately 1.4% of the outstanding PMI shares, had been tendered pursuant to notices of guaranteed delivery.
Pursuant to the terms of the merger agreement, Covidien Delaware, a wholly owned subsidiary of Covidien, exercised its option to purchase newly issued shares from PMI at the tender offer price. This permitted Covidien Delaware to acquire sufficient shares to effect a short-form merger with and into PMI, which then became a wholly owned subsidiary of Covidien.
Scott Flora, president of surgical devices at Covidien, said: "The acquisition of Power Medical will expand our stapling product line and is consistent with our strategy to deliver healthcare solutions that enable advanced surgical care. As a pioneer in surgical stapling, we are committed to advancing healthcare technology to improve patient outcomes."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index